SPRB
Vanguard Group’s Spruce Biosciences, Inc. Common Stock SPRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-843,844
| Closed | -$245K | – | 4345 |
|
|
2025
Q1 | $245K | Hold |
843,844
| – | – | ﹤0.01% | 4029 |
|
|
2024
Q4 | $354K | Hold |
843,844
| – | – | ﹤0.01% | 4020 |
|
|
2024
Q3 | $401K | Sell |
843,844
-19,531
| -2% | -$9.28K | ﹤0.01% | 4027 |
|
|
2024
Q2 | $447K | Hold |
863,375
| – | – | ﹤0.01% | 4039 |
|
|
2024
Q1 | $679K | Buy |
863,375
+40,985
| +5% | +$32.2K | ﹤0.01% | 3936 |
|
|
2023
Q4 | $2.41M | Buy |
822,390
+494,121
| +151% | +$1.45M | ﹤0.01% | 3537 |
|
|
2023
Q3 | $742K | Buy |
328,269
+66,315
| +25% | +$150K | ﹤0.01% | 3937 |
|
|
2023
Q2 | $563K | Buy |
261,954
+15,376
| +6% | +$33.1K | ﹤0.01% | 4086 |
|
|
2023
Q1 | $545K | Buy |
246,578
+121,465
| +97% | +$268K | ﹤0.01% | 4103 |
|
|
2022
Q4 | $137K | Buy |
125,113
+134
| +0.1% | +$147 | ﹤0.01% | 4356 |
|
|
2022
Q3 | $171K | Buy |
124,979
+8,921
| +8% | +$12.2K | ﹤0.01% | 4438 |
|
|
2022
Q2 | $202K | Sell |
116,058
-37,678
| -25% | -$65.6K | ﹤0.01% | 4468 |
|
|
2022
Q1 | $309K | Sell |
153,736
-218,391
| -59% | -$439K | ﹤0.01% | 4466 |
|
|
2021
Q4 | $1.66M | Buy |
372,127
+1,277
| +0.3% | +$5.7K | ﹤0.01% | 4108 |
|
|
2021
Q3 | $2.23M | Buy |
370,850
+1,330
| +0.4% | +$7.99K | ﹤0.01% | 4031 |
|
|
2021
Q2 | $4.14M | Buy |
369,520
+181,003
| +96% | +$2.03M | ﹤0.01% | 3686 |
|
|
2021
Q1 | $3.13M | Buy |
188,517
+4,459
| +2% | +$74K | ﹤0.01% | 3744 |
|
|
2020
Q4 | $4.47M | Buy |
+184,058
| New | +$4.47M | ﹤0.01% | 3414 |
|